Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

243 public trials 72 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Active, not recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations
  • Stanford University San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 36 locations
View Trial Details
Active, not recruiting

A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

NCT05868265

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Active, not recruiting

Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2

NCT05911295

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Banner Gateway Medical Center Gilbert, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCLA Hematology/Oncology - Alhambra Alhambra, California, United States
  • Foothill Cardioology Arcadia, California, United States
View all 268 locations
View Trial Details
Active, not recruiting

Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO

NCT05078047

Conditions
Adenocarcinoma, Basal Cell Carcinoma, Breast Diseases, +69 more
Locations
  • Institut de cancérologie de l'Ouest Angers, France
  • Clinique Sainte Catherine Avignon, France
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • CHU Bordeaux - Hôpial Saint André Bordeaux, France
View all 33 locations
View Trial Details
Active, not recruiting

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

NCT03317158

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +15 more
Locations
  • BCG Oncology Phoenix, Arizona, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

NCT06111235

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations
  • Urology Centers of Alabama PC Homewood, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Arizona Institute of Urology PLLC Tucson, Arizona, United States
View all 95 locations
View Trial Details
Active, not recruiting

Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma

NCT03967977

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
View all 46 locations
View Trial Details
Active, not recruiting

Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors

NCT02717156

Conditions
Carcinoma, Carcinoma, Transitional Cell, Genital Diseases, +14 more
Locations
  • City of Hope Duarte, California, United States
  • LAC+USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • USC Norris Oncology/Hematology - Newport Beach Newport Beach, California, United States
View Trial Details

Related conditions